Company Information
USD
7.45
- (5.7%)
NASDAQ:OCUL, OCULAR THERAPEUTIX, INC.
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Address
24 Crosby Drive
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Charles Warden
Director
Dr. Jeffrey S. Heier, M.D.
Chief Scientific Officer
Dr. Pravin U. Dugel, M.D.
Chairman of the Board/Director
Dr. Sanjay Nayak, M.B.B.S.,PhD
Chief Strategy Officer
Mr. Peter Kaiser, M.D.
Other Corporate Officer
Dr. Adrienne L. Graves,PhD
Director
Ms. Merilee Raines
Director
Dr. Richard L. Lindstrom,M.D.
Director
Mr. Christopher G. White
Other Executive Officer
Mr. Antony C. Mattessich
CEO/Director/President
Mr. Donald Notman
CFO/Chief Accounting Officer
Ms. Leslie J. Williams
Director
Dr. Seung Suh Hong, PhD
Director
Dr. Rabia Gurses Ozden
Chief Medical Officer
Mr. Philip C. Strassburger
General Counsel
Ownership
Institution Holdings
Deep Track Capital, LP
9,230,769 (8.038%)
Venrock Healthcare Capital Partners III, L.P.
7,775,760 (6.771%)
SUMMER ROAD LLC
7,660,550 (6.671%)
Opaleye Management Inc
6,070,000 (5.286%)
BlackRock Inc
5,761,533 (5.017%)
Vanguard Group Inc
5,118,102 (4.457%)
Franklin Resources Inc
4,500,159 (3.919%)
Logos Global Management LP
4,000,000 (3.483%)
Vanguard Investments Australia Ltd
3,289,162 (2.864%)
Franklin Advisers, Inc.
3,173,500 (2.763%)
Funds Holdings
iShares Russell 2000 ETF
1,967,285 (1.713%)
Vanguard Institutional Extnd Mkt Idx Tr
1,187,879 (1.034%)
Fidelity Small Cap Index Fund
797,528 (0.694%)
iShares Russell 2000 Growth ETF
709,975 (0.618%)
State Street Russell Small/Mid Cap®
467,566 (0.407%)
Fidelity Extended Market Index Fund
444,821 (0.387%)
State Street Russell Small Cap® Index
273,593 (0.238%)
Vanguard Russell 2000 Index Fund
269,277 (0.234%)
NT R2000 Growth Index Fund - NL
230,533 (0.201%)
NT R2000 Index Fund - NL
221,106 (0.193%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
